Paraquat and iron exposure as possible synergistic environmental risk factors in Parkinson's disease

被引：31

作者：

Andersen, JK ^{[1
]}

机构：

[1] Buck Inst Age Res, Novato, CA 94945 USA

来源：

NEUROTOXICITY RESEARCH | 2003年 / 5卷 / 05期

关键词：

D O I：

10.1007/BF03033150

中图分类号：

Q189 [神经科学];

学科分类号：

071006 ;

摘要：

[No abstract available]

引用

页码：307 / 313

页数：7

共 91 条

[61] Crosslinking of α-synuclein by advanced glycation endproducts -: an early pathophysiological step in Lewy body formation? [J].

Münch, G ;

Lüth, HJ ;

Wong, A ;

Arendt, T ;

Hirsch, E ;

Ravid, R ;

Riederer, P .

JOURNAL OF CHEMICAL NEUROANATOMY, 2000, 20 (3-4) :253-257

[62] The A53T α-synuclein mutation increases iron-dependent aggregation and toxicity [J].

Ostrerova-Golts, N ;

Petrucelli, L ;

Hardy, J ;

Lee, JM ;

Farer, M ;

Wolozin, B .

JOURNAL OF NEUROSCIENCE, 2000, 20 (16) :6048-6054

[63] Copper(II)-induced self-oligomerization of α-synuclein [J].

Paik, SR ;

Shin, HJ ;

Lee, JH ;

Chang, CS ;

Kim, J .

BIOCHEMICAL JOURNAL, 1999, 340 :821-828

[64] PARAQUAT AND 2 ENDOGENOUS ANALOGS OF THE NEUROTOXIC SUBSTANCE N-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE DO NOT DAMAGE DOPAMINERGIC NIGROSTRIATAL NEURONS IN THE MOUSE [J].

PERRY, TL ;

YONG, VW ;

WALL, RA ;

JONES, K .

NEUROSCIENCE LETTERS, 1986, 69 (03) :285-289

[65] IDIOPATHIC PARKINSONS-DISEASE, PROGRESSIVE SUPRANUCLEAR PALSY AND GLUTATHIONE METABOLISM IN THE SUBSTANTIA-NIGRA OF PATIENTS [J].

PERRY, TL ;

YONG, VW .

NEUROSCIENCE LETTERS, 1986, 67 (03) :269-274

[66] PARKINSONS-DISEASE - A DISORDER DUE TO NIGRAL GLUTATHIONE DEFICIENCY [J].

PERRY, TL ;

GODIN, DV ;

HANSEN, S .

NEUROSCIENCE LETTERS, 1982, 33 (03) :305-310

[67] THE SPECIFIC VULNERABILITY OF THE SUBSTANTIA NIGRA TO MPTP IS RELATED TO THE PRESENCE OF TRANSITION-METALS [J].

POIRIER, J ;

DONALDSON, J ;

BARBEAU, A .

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1985, 128 (01) :25-33

[68] Mutation in the alpha-synuclein gene identified in families with Parkinson's disease [J].

Polymeropoulos, MH ;

Lavedan, C ;

Leroy, E ;

Ide, SE ;

Dehejia, A ;

Dutra, A ;

Pike, B ;

Root, H ;

Rubenstein, J ;

Boyer, R ;

Stenroos, ES ;

Chandrasekharappa, S ;

Athanassiadou, A ;

Papapetropoulos, T ;

Johnson, WG ;

Lazzarini, AM ;

Duvoisin, RC ;

DiIorio, G ;

Golbe, LI ;

Nussbaum, RL .

SCIENCE, 1997, 276 (5321) :2045-2047

[69] The parkinsonian toxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): a technical review of its utility and safety [J].

Przedborski, S ;

Jackson-Lewis, V ;

Naini, AB ;

Jakowec, M ;

Petzinger, G ;

Miller, R ;

Akram, M .

JOURNAL OF NEUROCHEMISTRY, 2001, 76 (05) :1265-1274

[70] TRANSITION-METALS, FERRITIN, GLUTATHIONE, AND ASCORBIC-ACID IN PARKINSONIAN BRAINS [J].

RIEDERER, P ;

SOFIC, E ;

RAUSCH, WD ;

SCHMIDT, B ;

REYNOLDS, GP ;

JELLINGER, K ;

YOUDIM, MBH .

JOURNAL OF NEUROCHEMISTRY, 1989, 52 (02) :515-520

← 1 2 3 4 5 6 7 8 9 10 →